| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0272-5231(03)00097-2 |
| P698 | PubMed publication ID | 14710698 |
| P2093 | author name string | Babak Mokhlesi | |
| Thomas Corbridge | |||
| P2860 | cites work | Smallpox as a Biological Weapon | Q22918878 |
| Botulinum Toxin as a Biological Weapon: Medical and Public Health Management | Q23832736 | ||
| Heroin insufflation as a trigger for patients with life-threatening asthma | Q23910006 | ||
| Nosocomial poisoning associated with emergency department treatment of organophosphate toxicity Georgia 2000 | Q23919691 | ||
| Diuresis or urinary alkalinisation for salicylate poisoning? | Q24550814 | ||
| Intensive care management of organophosphate insecticide poisoning | Q24802531 | ||
| Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone | Q28258743 | ||
| Use of phentolamine for cocaine-induced myocardial ischemia | Q28320645 | ||
| Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure | Q28333321 | ||
| Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine | Q28334205 | ||
| Effects of labetalol treatment on the physiological and subjective response to smoked cocaine | Q28370417 | ||
| APACHE II: a severity of disease classification system | Q29547729 | ||
| Anthrax as a biological weapon, 2002: updated recommendations for management | Q29615587 | ||
| Population-based incidence and outcome of acetaminophen poisoning by type of ingestion | Q30304467 | ||
| Nuclear terrorism. | Q30330478 | ||
| Fomepizole for the treatment of methanol poisoning | Q31921338 | ||
| Phosgene exposure: mechanisms of injury and treatment strategies | Q32066461 | ||
| Isopropanol ingestion: a report of six episodes with isopropanol and acetone serum concentration time data | Q33522510 | ||
| Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place? | Q40619858 | ||
| Pulse oximetry: principles and limitations | Q40826034 | ||
| Pulmonary complications following tricyclic antidepressant overdose in an adolescent | Q40832806 | ||
| Sites of action of gamma-hydroxybutyrate (GHB)--a neuroactive drug with abuse potential | Q40910671 | ||
| Hyperbaric-oxygen therapy | Q40985255 | ||
| Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") | Q41110153 | ||
| Approach to the poisoned patient | Q41141256 | ||
| Chemical warfare. Nerve agent poisoning | Q41612505 | ||
| Confirmation of the pulse oximetry gap in carbon monoxide poisoning. | Q41635167 | ||
| Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications | Q33548208 | ||
| Acute heroin overdose | Q33585715 | ||
| Anthrax | Q33728930 | ||
| Management of self poisoning | Q33780841 | ||
| Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study | Q33793802 | ||
| Chemical weapons | Q33809061 | ||
| Inhaled heroin-induced status asthmaticus: five cases and a review of the literature | Q33814712 | ||
| Hyperbaric oxygen for acute carbon monoxide poisoning | Q33845864 | ||
| Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group | Q33855295 | ||
| Prevalence of drugs used in cases of alleged sexual assault | Q33864897 | ||
| ECG abnormalities in tricyclic antidepressant ingestion | Q33871422 | ||
| Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose | Q33882477 | ||
| Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? | Q33882484 | ||
| Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose | Q33895827 | ||
| Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense | Q33901607 | ||
| Substance abuse and acute asthma | Q33925711 | ||
| Acute hepatic failure: a Western perspective | Q33939738 | ||
| Tularemia as a biological weapon: medical and public health management | Q33949367 | ||
| Current management of ethylene glycol poisoning | Q33953389 | ||
| Antidote review: fomepizole for methanol poisoning | Q33963664 | ||
| Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) | Q34048790 | ||
| Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen | Q34058639 | ||
| Osmol gaps revisited: normal values and limitations. | Q34061735 | ||
| 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System | Q34091187 | ||
| Hemorrhagic fever viruses as biological weapons: medical and public health management | Q34126496 | ||
| Acute salicylate self-poisoning in 177 consecutive patients treated in ICU. | Q34184887 | ||
| Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants | Q34199178 | ||
| Nerve agents: A review | Q34235343 | ||
| Hydroxocobalamin: improved public health readiness for cyanide disasters | Q34269208 | ||
| Delayed neurologic sequelae in carbon monoxide intoxication | Q34272001 | ||
| Clinical features of patients with acute organophosphate poisoning requiring intensive care | Q34277700 | ||
| Acute and chronic effects of aspirin toxicity and their treatment | Q34288147 | ||
| The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail'. | Q34301844 | ||
| A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose | Q34337710 | ||
| Ricin | Q34398284 | ||
| Acetaminophen overdose | Q70305728 | ||
| Treatment of heroin overdose with endotracheal naloxone | Q70420976 | ||
| Heroin pulmonary edema. Evidence for increased pulmonary capillary permeability | Q70500736 | ||
| Delayed Encephalopathy Following Carbon Monoxide Intoxication | Q70755721 | ||
| Salicylate-induced pulmonary edema. Clinical features and prognosis | Q70932843 | ||
| Pharmacokinetics of hydroxocobalamin in smoke inhalation victims | Q71238092 | ||
| An assessment of the unreliability of the history given by self-poisoned patients | Q71263816 | ||
| Meperidine and central neurotoxicity | Q71700583 | ||
| The pulse oximetry gap in carbon monoxide intoxication | Q72075277 | ||
| Relationship between venous and arterial carboxyhemoglobin levels in patients with suspected carbon monoxide poisoning | Q72141169 | ||
| Sarin poisoning in Tokyo subway | Q72152668 | ||
| Cardiovascular repercussions of seizures during cyclic antidepressant poisoning | Q72262442 | ||
| Comparison of three methods of gut decontamination in tricyclic antidepressant overdose | Q72299527 | ||
| Are activated charcoal-N-acetylcysteine interactions of clinical significance? | Q72604760 | ||
| Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kit | Q72907158 | ||
| Fatalities attributed to GHB and related compounds | Q73148698 | ||
| Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists | Q73234859 | ||
| Postexposure treatment with aminophylline protects against phosgene-induced acute lung injury | Q73458185 | ||
| Physostigmine in the treatment of gamma-hydroxybutyric acid overdose | Q73668229 | ||
| Pancreatic injury following acute methanol poisoning | Q73923072 | ||
| Intravenous administration of oral N-acetylcysteine | Q74037629 | ||
| Physostigmine treatment of gamma-hydroxybutyric acid overdose: appropriate or inappropriate use of a reversal agent? | Q74174313 | ||
| CHRONIC SALICYLATE INTOXICATION IN ADULTS | Q78444413 | ||
| Position statement: cathartics. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists | Q41712526 | ||
| Position statement: whole bowel irrigation. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists | Q41712528 | ||
| Secondary exposure of medical staff to sarin vapor in the emergency room | Q42060400 | ||
| Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group | Q42064036 | ||
| Salicylate poisoning from enteric-coated aspirin. Delayed absorption may complicate management | Q42072513 | ||
| Plasma catecholamine levels in cyclic antidepressant overdose | Q42072994 | ||
| Quantitative serum toxic screening in the management of suspected drug overdose | Q42076166 | ||
| Impact of drug screening in suspected overdose | Q42081670 | ||
| Complications after overdose with tricyclic antidepressants | Q42086657 | ||
| Epidemiology of fatal tricyclic antidepressant ingestion: implications for management | Q42087610 | ||
| Cyanide poisoning treated with hyperbaric oxygen | Q42089984 | ||
| Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning | Q42277553 | ||
| Earlier identification of patients at risk from acetaminophen-induced acute liver failure | Q42545008 | ||
| Meperidine-induced generalized seizures with normal renal function | Q42549463 | ||
| Influence of labetalol on cocaine-induced coronary vasoconstriction in humans | Q42558199 | ||
| Cardiovascular complications of cocaine use. | Q43694987 | ||
| Index case of fatal inhalational anthrax due to bioterrorism in the United States | Q43796773 | ||
| The intravenous use of oral acetylcysteine (mucomyst) for the treatment of acetaminophen overdose | Q43849812 | ||
| Validation of a brief observation period for patients with cocaine-associated chest pain. | Q44305031 | ||
| Beneficial effect of norepinephrine in the treatment of circulatory shock caused by tricyclic antidepressant overdose | Q45076242 | ||
| Pulse oximetry in severe carbon monoxide poisoning | Q45114465 | ||
| Is measurement of venous oxygen saturation useful in the diagnosis of cyanide poisoning? | Q45140657 | ||
| Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. | Q45996959 | ||
| Clinical confirmation of organophosphate poisoning by serial cholinesterase analyses. | Q46038282 | ||
| Prognostic value of serum cholinesterase in organophosphate poisoning | Q46574164 | ||
| Images in clinical medicine. Methemoglobinemia. | Q50510285 | ||
| Bilateral facial paralysis following ethylene glycol ingestion. | Q50577679 | ||
| Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. | Q51036581 | ||
| Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS. | Q51379017 | ||
| Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. | Q51707971 | ||
| Experience with esmolol for the treatment of cocaine-associated cardiovascular complications | Q51716308 | ||
| Acute Rhabdomyolysis Associated with Cocaine Intoxication | Q51767371 | ||
| William Osler: narcotic-induced pulmonary edema. | Q52411660 | ||
| Poisoning due to organophosphate insecticides. Acute and chronic manifestations. | Q52473150 | ||
| Toxicokinetic and toxicodynamic aspects of organophosphorus (OP) insecticide poisoning. | Q52568376 | ||
| Criteria for admitting patients with tricyclic antidepressant overdose. | Q52569767 | ||
| Etiology and outcome for 295 patients with acute liver failure in the United States. | Q52907526 | ||
| Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients. | Q53992474 | ||
| Unintentional carbon monoxide-related deaths in the United States, 1979 through 1988 | Q56287910 | ||
| Interrater Agreement in the Measurement of QRS Interval in Tricyclic Antidepressant Overdose: Implications for Monitoring and Research | Q57809849 | ||
| Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning | Q66979484 | ||
| Unrecognized adult salicylate intoxication | Q67876022 | ||
| Ethylene glycol intoxication | Q68271906 | ||
| Pulse oximetry | Q69482982 | ||
| Acetaminophen overdose in children and adolescents | Q69528313 | ||
| Phenytoin: does it reverse tricyclic-antidepressant-induced cardiac conduction abnormalities? | Q69584267 | ||
| Serum Osmolality and Its Applicability to Drug Overdose | Q69606728 | ||
| The missing gap. A pitfall in the diagnosis of alcohol intoxication by osmometry | Q69608627 | ||
| Cranial nerve deficit: a clue to the diagnosis of ethylene glycol poisoning | Q69646477 | ||
| Pulmonary consequences of severe tricyclic antidepressant ingestion | Q69914394 | ||
| Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry | Q69938558 | ||
| Recognition and management of anthrax--an update | Q34435312 | ||
| Heroin-related noncardiogenic pulmonary edema : a case series | Q34442464 | ||
| Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists | Q34458147 | ||
| Management of anaphylactoid reactions to intravenous N-acetylcysteine | Q34471517 | ||
| Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit? | Q34473931 | ||
| Biological and chemical agents: a brief synopsis | Q34488054 | ||
| Viral agents as biological weapons and agents of bioterrorism | Q34524309 | ||
| Diagnosis and management of smallpox | Q34581865 | ||
| Bacterial pathogens as biological weapons and agents of bioterrorism | Q34695946 | ||
| Microbiological, biological, and chemical weapons of warfare and terrorism | Q34695957 | ||
| Unconventional biological threats and the molecular biological response to biological threats | Q34695972 | ||
| A review of nerve agent exposure for the critical care physician | Q34978185 | ||
| Adult toxicology in critical care: part I: general approach to the intoxicated patient | Q35063246 | ||
| Nitroprusside-related cyanide poisoning. Time (long past due) for urgent, effective interventions | Q35535909 | ||
| Methanol poisoning | Q35614058 | ||
| Agents of chemical warfare: sulfur mustard | Q35886268 | ||
| Cardiac manifestations of acute carbamate and organophosphate poisoning | Q36843496 | ||
| Toxicology of mustard gas. | Q37773159 | ||
| The use of vasoactive agents in the treatment of refractory hypotension seen in tricyclic antidepressant overdose | Q38032325 | ||
| Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings | Q38119487 | ||
| Evaluation of the validity of the Done nomogram in the management of acute salicylate intoxication | Q39125330 | ||
| Neurological manifestation of carbon monoxide poisoning | Q39183747 | ||
| Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol | Q39251515 | ||
| The empiric use of naloxone in patients with altered mental status: a reappraisal | Q39253911 | ||
| Acetaminophen toxicity in an urban county hospital | Q39454333 | ||
| A pharmacokinetic comparison of acetaminophen products (Tylenol Extended Relief vs regular Tylenol) | Q39463344 | ||
| Clinical course of gamma-hydroxybutyrate overdose | Q39468799 | ||
| Pharmacokinetics of extended relief vs regular release Tylenol in simulated human overdose | Q39469621 | ||
| Extracorporeal techniques in the treatment of exogenous intoxications | Q39640340 | ||
| Role of the intensive care unit in the management of the poisoned patient. | Q39749542 | ||
| Physical assessment and differential diagnosis of the poisoned patient | Q39759028 | ||
| Salicylate intoxication | Q39925557 | ||
| Acute isopropyl alcohol intoxication. Diagnosis and management | Q40232003 | ||
| Stimulant-induced pulmonary toxicity | Q40411993 | ||
| Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan) | Q40451506 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 689-711 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Clinics in Chest Medicine | Q15754921 |
| P1476 | title | Toxicology in the critically ill patient | |
| P478 | volume | 24 |
| Q37132455 | Early onset muscarinic manifestations after wild mushroom ingestion. | cites work | P2860 |
Search more.